1.
Guidelines for the management of inflammatory bowel disease in adults
by Mowat, Craig
Gut, 2011, Vol.60 (5), p.571-607
2.
ESCMID∗ guideline for the diagnosis and treatment of biofilm infections 2014
by Høiby, N
Clinical microbiology and infection, 2015, Vol.21 (Suppl 1), p.S1-S25
3.
Management of infections related to totally implantable venous-access ports: challenges and perspectives
by Lebeaux, David, MD
The Lancet infectious diseases, 2014, Vol.14 (2), p.146-159
4.
The effects of antibiotic cycling and mixing on antibiotic resistance in intensive care units: a cluster-randomised crossover trial
by van Duijn, Pleun Joppe
The Lancet infectious diseases, 2018, Vol.18 (4), p.401-409
5.
Listeria monocytogenes-associated respiratory infections: a study of 38 consecutive cases
by Morgand, M
Clinical microbiology and infection, 2018, Vol.24 (12), p.1339.e1-1339.e5
6.
New agents for the treatment of infections with Gram-negative bacteria: restoring the miracle or false dawn?
by Wright, H
Clinical microbiology and infection, 2017, Vol.23 (10), p.704-712
7.
Helicobacter bilis-Associated Suppurative Cholangitis in a Patient with X-Linked Agammaglobulinemia
by Degand, Nicolas
Journal of clinical immunology, 2017, Vol.37 (7), p.727-731
8.
Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus
by Nation, Roger L, Prof
The Lancet infectious diseases, 2015, Vol.15 (2), p.225-234
9.
Nanosilver as a new generation of nanoproduct in biomedical applications
by Chaloupka, Karla
Trends in biotechnology (Regular ed.), 2010, Vol.28 (11), p.580-588
10.
Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis
by Schuts, Emelie C, BSc
The Lancet infectious diseases, 2016, Vol.16 (7), p.847-856
11.
Prevalence of Atopy and Allergic Diseases in Korean Children: Associations with a Farming Environment and Rural Lifestyle
by Lee, S.Y
International archives of allergy and immunology, 2012, Vol.158 (2), p.168-174
12.
Alternatives to antibiotics—a pipeline portfolio review
by Czaplewski, Lloyd, Dr
The Lancet infectious diseases, 2016, Vol.16 (2), p.239-251
13.
Non-prescription antimicrobial use worldwide: a systematic review
by Morgan, Daniel J, Dr
The Lancet infectious diseases, 2011, Vol.11 (9), p.692-701
14.
The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection
by Mazuski, John E.
Surgical infections, 2017, Vol.18 (1), p.1-76
15.
Antimicrobial strategies centered around reactive oxygen species – bactericidal antibiotics, photodynamic therapy, and beyond
by Vatansever, Fatma
FEMS microbiology reviews, 2013, Vol.37 (6), p.955-989
16.
Community-acquired pneumonia
by Prina, Elena, MD
The Lancet (British edition), 2015, Vol.386 (9998), p.1097-1108
17.
Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial
by Brusselle, Guy G
Thorax, 2013, Vol.68 (4), p.322-329
18.
Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study
by Teillant, Aude, MS
The Lancet infectious diseases, 2015, Vol.15 (12), p.1429-1437
19.
IgE-mediated hypersensitivity to cephalosporins: Cross-reactivity and tolerability of alternative cephalosporins
by Romano, Antonino, MD
Journal of allergy and clinical immunology, 2015, Vol.136 (3), p.685-691.e3
20.
British Thoracic Society guideline for non-CF bronchiectasis
by Pasteur, M C
Thorax, 2010, Vol.65 Suppl 1, p.i1-58
